CEL-SCI to Partner With Leading Saudi Pharma Firm to Advance Multikine for Head and Neck Cancer Treatment Today announced it has reached an agreement with one of Saudi Arabia’s premier…
Personalis Expands Tempus Partnership to Deliver Ultra-Sensitive Recurrence Testing for Colorectal Cancer Today announced an expansion and extension of its strategic collaboration with Tempus AI, Inc. (Nasdaq: TEM), adding a…
OhioGuidestone, Ohio’s leader in community behavioral healthcare, announced today the expansion of its partnership with Greenspace Health, extending the use of its Measurement-Based Care (MBC) technology across the organization’s behavioral health…
A technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, proudly recognizes DAB Transport’s outstanding commitment to service central Georgia with…
Bicycle Therapeutics plc today announced that on July 1, 2025, the Compensation Committee of the company’s Board of Directors granted to eight new employees inducement awards consisting of non-qualified share…
The 40th barometer from Sermo, a fast, frictionless HCP engagement platform providing the healthcare industry with real-time business insights and authentic physician touch points, of 1,000+ global healthcare providers (HCPs) found…
Clinical Results of iPSC-CAR-NK Cell Therapy Published in Cell, Marking a Global Breakthrough in Autoimmune Disease Treatment Hangzhou Qihan Biotech Co., Ltd. (“Qihan” or “Qihan Biotech” or “the Company”), an…
Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) and Superluminal Medicines, Inc. (Superluminal) announced the intention to collaborate on drug discovery targeting specific molecular mechanisms associated with challenging biological targets. The…
Today released its fifth annual Healthcare Consumer Report, unveiling key insights into consumer sentiment about their health insurance plans. This year’s findings highlight the growing importance of affordability, transparency, member…
FDA Approves KEYTRUDA® for PD-L1+ Head & Neck Cancer in Neoadjuvant and Adjuvant Settings Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that the…
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced a strategic collaboration with Thermo Fisher Scientific, the world leader in serving science, to provide a…
MDP Completes Acquisition of Significant Ownership Position in NextGen Healthcare and Partners with Thoma Bravo and Company Management to Accelerate NextGen Healthcare’s Growth NextGen Healthcare President and COO Srinivas (Sri)…